Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1972 1
1973 1
1974 5
1975 32
1976 20
1977 30
1978 38
1979 39
1980 48
1981 48
1982 60
1983 55
1984 46
1985 66
1986 55
1987 27
1988 31
1989 29
1990 28
1991 23
1992 12
1993 21
1994 9
1995 12
1996 15
1997 18
1998 6
1999 13
2000 8
2001 8
2002 7
2003 9
2004 5
2005 6
2006 13
2007 8
2008 5
2009 6
2010 8
2011 7
2012 9
2013 12
2014 8
2015 10
2016 8
2017 10
2018 10
2019 12
2020 15
2021 9
2022 9
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

981 results

Results by year

Filters applied: . Clear all
Page 1
Acebutolol.
[No authors listed] [No authors listed] 2024 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 May 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000200 Free Books & Documents. Review.
Because of the relatively extensive excretion of acebutolol and its active metabolite diacetolol into breastmilk and some possible reports of adverse reactions in breastfed infants, other agents are preferred, especially while nursing a newborn or preterm infant.[1-3]...
Because of the relatively extensive excretion of acebutolol and its active metabolite diacetolol into breastmilk and some possible re …
Acebutolol.
[No authors listed] [No authors listed] 2017 Jan 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jan 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644160 Free Books & Documents. Review.
Acebutolol is a cardioselective beta-blocker used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. Acebutolol has been linked to several instances of clinically apparent drug induced liver injury....
Acebutolol is a cardioselective beta-blocker used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. Acebu …
Acebutolol: ten years of experience.
De Bono G, Kaye CM, Roland E, Summers AJ. De Bono G, et al. Am Heart J. 1985 May;109(5 Pt 2):1211-3. doi: 10.1016/0002-8703(85)90712-4. Am Heart J. 1985. PMID: 2859785 Review.
Acebutolol is cardioselective, and clinical use has borne out the low incidence of bronchospasm in patients with impaired lung function. ...A combination of selectivity and ISA may be responsible for the low incidence of tiredness and cold extremities observed with aceb …
Acebutolol is cardioselective, and clinical use has borne out the low incidence of bronchospasm in patients with impaired lung functi …
Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
Singh BN, Thoden WR, Wahl J. Singh BN, et al. Pharmacotherapy. 1986 Mar-Apr;6(2):45-63. doi: 10.1002/j.1875-9114.1986.tb03451.x. Pharmacotherapy. 1986. PMID: 3012486 Review.
Acebutolol is a new hydrophilic, cardioselective beta-adrenergic-blocking agent that possesses partial agonist and membrane-stabilizing activities. ...Controlled clinical trials documented the antianginal actions of oral acebutolol in chronic stable angina pectoris; …
Acebutolol is a new hydrophilic, cardioselective beta-adrenergic-blocking agent that possesses partial agonist and membrane-stabilizi …
Acebutolol.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 1985 Jul 5;27(691):58-60. Med Lett Drugs Ther. 1985. PMID: 3892259 Clinical Trial. No abstract available.
[Pharmacokinetics of acebutolol].
Collins RF. Collins RF. Nouv Presse Med. 1975 Dec 31;4(46 Suppl):3223-8. Nouv Presse Med. 1975. PMID: 768905 Clinical Trial. French.
It was shown, by calculation from the renal clearance, that the late biological half-life for the decline of 14C-acebutolol in plasma was 9.4 h and 13.2 h, respectively, in two of these patients treated with a single oral dose (200 mg) of 14C-acebutolol hydrochlorid …
It was shown, by calculation from the renal clearance, that the late biological half-life for the decline of 14C-acebutolol in plasma …
Acebutolol saliva excretion.
Giudicelli JF, Freslon JL, Richer C. Giudicelli JF, et al. Br J Clin Pharmacol. 1979 Oct;8(4):373-5. doi: 10.1111/j.1365-2125.1979.tb04724.x. Br J Clin Pharmacol. 1979. PMID: 41552 Free PMC article. No abstract available.
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Singh BN, Thoden WR, Ward A. Singh BN, et al. Drugs. 1985 Jun;29(6):531-69. doi: 10.2165/00003495-198529060-00003. Drugs. 1985. PMID: 3891306 Review.
Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membrane stabilising activity. ...In both angina and arrhythmia, when administered twice daily it has been as effective as standard therapeutic a …
Acebutolol is a cardioselective beta-adrenoceptor blocking drug possessing both partial agonist (intrinsic sympathomimetic) and membr …
Acebutolol-induced hypersensitivity pneumonitis.
Akoun GM, Herman DP, Mayaud CM, Perrot JY. Akoun GM, et al. Br Med J (Clin Res Ed). 1983 Jan 22;286(6361):266-7. doi: 10.1136/bmj.286.6361.266-a. Br Med J (Clin Res Ed). 1983. PMID: 6402066 Free PMC article. No abstract available.
Effects of acebutolol on the serum lipid profile.
Clucas A, Miller N. Clucas A, et al. Drugs. 1988;36 Suppl 2:41-50. doi: 10.2165/00003495-198800362-00008. Drugs. 1988. PMID: 3063505 Review.
The results indicate that, on average, acebutolol does not have any adverse effects on plasma lipids and may even reduce total and low density lipoprotein (LDL)-cholesterol by 7 and 5%, respectively. In contrast, the other beta-blockers compared under the same conditions ( …
The results indicate that, on average, acebutolol does not have any adverse effects on plasma lipids and may even reduce total and lo …
981 results